Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.

Prevost TC, Presanis AM, Taylor A, Goldberg DJ, Hutchinson SJ, De Angelis D.

Addiction. 2015 Apr 14. doi: 10.1111/add.12948. [Epub ahead of print]

PMID:
25876667
2.

Modeling the Initiation of Others Into Injection Drug Use, Using Data From 2,500 Injectors Surveyed in Scotland During 2008-2009.

White SR, Hutchinson SJ, Taylor A, Bird SM.

Am J Epidemiol. 2015 Mar 18. pii: kwu345. [Epub ahead of print]

PMID:
25787265
3.

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.

Innes HA, McDonald SA, Dillon JF, Allen S, Hayes PC, Goldberg D, Mills PR, Barclay ST, Wilks D, Valerio H, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Bramley P, Hutchinson SJ.

Hepatology. 2015 Feb 26. doi: 10.1002/hep.27766. [Epub ahead of print]

PMID:
25716707
4.

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?

Innes H, Goldberg D, Dillon J, Hutchinson SJ.

Gut. 2014 Nov 6. pii: gutjnl-2014-308166. doi: 10.1136/gutjnl-2014-308166. [Epub ahead of print]

PMID:
25378522
5.

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.

Martin NK, Foster GR, Vilar J, Ryder S, E Cramp M, Gordon F, Dillon JF, Craine N, Busse H, Clements A, Hutchinson SJ, Ustianowski A, Ramsay M, Goldberg DJ, Irving W, Hope V, De Angelis D, Lyons M, Vickerman P, Hickman M.

J Viral Hepat. 2015 Apr;22(4):399-408. doi: 10.1111/jvh.12338. Epub 2014 Oct 7.

PMID:
25288193
6.

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland.

McAllister G, Innes H, Mcleod A, Dillon JF, Hayes PC, Fox R, Barclay ST, Templeton K, Aitken C, Gunson R, Goldberg D, Hutchinson SJ.

J Clin Virol. 2014 Nov;61(3):359-64. doi: 10.1016/j.jcv.2014.09.004. Epub 2014 Sep 16.

PMID:
25264306
7.

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.

Aspinall EJ, Hutchinson SJ, Janjua NZ, Grebely J, Yu A, Alavi M, Amin J, Goldberg DJ, Innes H, Law M, Walter SR, Krajden M, Dore GJ.

J Hepatol. 2015 Feb;62(2):269-77. doi: 10.1016/j.jhep.2014.09.001. Epub 2014 Sep 6.

PMID:
25200903
8.

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?

McDonald SA, Innes HA, Hayes PC, Dillon JF, Mills PR, Goldberg DJ, Barclay S, Allen S, Fox R, Fraser A, Kennedy N, Bhattacharyya D, Hutchinson SJ.

J Hepatol. 2015 Feb;62(2):262-8. doi: 10.1016/j.jhep.2014.08.046. Epub 2014 Sep 6.

PMID:
25195556
9.

Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions.

Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, McAllister G, Gunson R, Hutchinson SJ.

PLoS One. 2014 Aug 11;9(8):e104515. doi: 10.1371/journal.pone.0104515. eCollection 2014.

10.

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.

McDonald SA, Hutchinson SJ, Innes HA, Allen S, Bramley P, Bhattacharyya D, Carman W, Dillon JF, Fox R, Fraser A, Goldberg DJ, Kennedy N, Mills PR, Morris J, Stanley AJ, Wilks D, Hayes PC.

J Viral Hepat. 2014 May;21(5):366-76. doi: 10.1111/jvh.12153. Epub 2013 Sep 2.

PMID:
24716639
11.

Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model.

Innes H, Goldberg D, Dusheiko G, Hayes P, Mills PR, Dillon JF, Aspinall E, Barclay ST, Hutchinson SJ.

J Hepatol. 2014 Jun;60(6):1118-26. doi: 10.1016/j.jhep.2014.01.020. Epub 2014 Feb 5.

PMID:
24509410
12.

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ.

Int J Epidemiol. 2014 Feb;43(1):235-48. doi: 10.1093/ije/dyt243. Epub 2013 Dec 27. Review.

13.

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

Aspinall EJ, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P, Hutchinson SJ, Hellard ME.

Int J Drug Policy. 2014 Jan;25(1):179-82. doi: 10.1016/j.drugpo.2013.08.005. Epub 2013 Sep 8.

PMID:
24315504
14.

Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland.

Overstall AM, King R, Bird SM, Hutchinson SJ, Hay G.

Stat Med. 2014 Apr 30;33(9):1564-79. doi: 10.1002/sim.6047. Epub 2013 Dec 1.

15.

The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance.

O'Leary MC, Sarwar M, Hutchinson SJ, Weir A, Schofield J, McLeod A, Cameron S, McTaggart C, Banday S, Foster GR, Ahmed S, Fox R, Mills PR, Goldberg DJ, Anderson E.

Travel Med Infect Dis. 2013 Sep-Oct;11(5):301-9. doi: 10.1016/j.tmaid.2013.08.001. Epub 2013 Aug 23.

PMID:
24007935
16.

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ.

Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Review.

PMID:
23973009
17.

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons.

Martin NK, Hickman M, Miners A, Hutchinson SJ, Taylor A, Vickerman P.

BMJ Open. 2013 Aug 13;3(8). pii: e003153. doi: 10.1136/bmjopen-2013-003153.

18.

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

Aspinall EJ, Corson S, Doyle JS, Grebely J, Hutchinson SJ, Dore GJ, Goldberg DJ, Hellard ME.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S80-9. doi: 10.1093/cid/cit306. Review.

19.

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S39-45. doi: 10.1093/cid/cit296. Erratum in: Clin Infect Dis. 2014 Apr;58(8):1203.

20.

Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates.

King R, Bird SM, Overstall A, Hay G, Hutchinson SJ.

Addict Res Theory. 2013 Jun;21(3):235-246. Epub 2012 Aug 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk